Zevra (ZVRA) Rises on Update on Niemann-Pick Disease Type C Drug

view original post

Zevra Therapeutics, Inc. ZVRA announced that the FDA has indicated that it will convene a meeting with the recently formed Genetic Metabolic Diseases Advisory Committee (“GeMDAC”) to review the …